Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139318 · ClinicalTrials.gov registry record · NA
Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03139318 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 1 participants.
The verdict
NCT03139318, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the toxicity profile of GRID therapy using dose levels of 10Gy, 15 Gy and 20Gy in pediatric osteosarcoma of the extremity.
Interventions
- RADIATION GRID radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-07-25 |
| Est. Completion | 2018-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03139318
The ClinicalTrials.gov registry entry for NCT03139318 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GRID radiotherapy is the first listed.
NCT03139318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03139318 about?
NCT03139318 is a clinical study titled "Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity". The primary objective of this study is to evaluate the toxicity profile of GRID therapy using dose levels of 10Gy, 15 Gy and 20Gy in pediatric osteosarcoma of the extremity.
What is the current status of trial NCT03139318?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-07-25. Estimated completion is 2018-08-29.
What interventions are being tested in trial NCT03139318?
The interventions under investigation include: GRID radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT03139318?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.